Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTT | P42858 | 1/20 | 1.00 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.54 |
| ▸ | BCHE | P06276 | 5/20 | 0.47 |
| ▸ | ACHE | P22303 | 5/20 | 0.47 |
| ▸ | GRIN1 | Q05586 | 5/20 | 0.47 |
| ▸ | GRIN2A | Q12879 | 5/20 | 0.47 |
| ▸ | NT5E | P21589 | 1/20 | 0.47 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.44 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.44 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.44 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 2/20 | 0.43 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.42 |
| ▸ | JAK2 | O60674 | 1/20 | 0.42 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.42 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.41 |
| ▸ | MPO | P05164 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8897424 | 1.00 | HTT (1.00) | HTTADRB2BCHEACHEGRIN1 | |
| SCHEMBL29663118 | 0.85 | HTT (0.74) | HTTADRB2BCHEACHEGRIN1 | |
| SCHEMBL19876615 | 0.85 | HTT (0.74) | HTTADRB2BCHEACHEGRIN1 | |
| SCHEMBL29441517 | 0.81 | HTT (0.68) | HTTBCHEACHEGRIN1GRIN2A | |
| SCHEMBL4358438 | 0.81 | HTT (0.68) | HTTADRB2PABPC1ADORA2A | |
| SCHEMBL21500731 | 0.81 | HTT (0.68) | HTTBCHEACHEGRIN1GRIN2A | |
| SCHEMBL182719 | 0.81 | HTT (0.68) | HTTBCHEACHEGRIN1GRIN2A | |
| SCHEMBL29649743 | 0.81 | HTT (0.68) | HTTADRB2PABPC1ADORA2A | |
| SCHEMBL30973214 | 0.79 | HTT (0.65) | HTTADRB2BCHEACHEGRIN1 | |
| SCHEMBL3778992 | 0.78 | HTT (0.64) | HTTBCHEACHEGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-221123533-U | Capacitive cooling liquid level sensor | 奥卡冷却系统（天津）有限公司 | 2024-06-11 | — | — | CN | claimed |
| US-12534730-B2 | Compositions and methods for inhibiting GYS2 expression | NOVO NORDISK A/S (DK) | 2026-01-27 | — | — | US | disclosed |
| US-20250270075-A1 | SYSTEMS AND METHODS FOR IDENTIFYING AND LOCATING BUILDING MATERIAL OBJECTS | STRUCTURAL SERVICES INC (US) | 2025-08-28 | — | — | US | disclosed |
| EP-4567112-A1 | RNA INHIBITOR FOR INHIBITING APOC3 GENE EXPRESSION AND USE THEREOF | Kylonova (Xiamen) Biopharma Co., Ltd. (CN) | 2025-06-11 | — | — | EP | disclosed |
| CN-111901919-B | Phase-cut dimming input signal detection circuit and method | 赛尔富电子有限公司 | 2025-05-16 | — | — | CN | disclosed |
| US-20250145424-A1 | SYSTEMS AND METHODS FOR IDENTIFYING AND LOCATING BUILDING MATERIAL OBJECTS | STRUCTURAL SERVICES INC (US) | 2025-05-08 | — | — | US | disclosed |
| US-12195306-B2 | Systems and methods for identifying and locating building material objects | STRUCTURAL SERVICES, INC. (US) | 2025-01-14 | — | — | US | disclosed |
| CN-114825939-B | High-precision switching power supply circuit based on double-group output of single transformer | 冠捷电子科技(福建)有限公司 | 2024-10-22 | — | — | CN | disclosed |
| WO-2024172819-A1 | SYSTEMS AND METHODS FOR IDENTIFYING AND LOCATING BUILDING MATERIAL OBJECTS | STRUCTURAL SERVICES, INC. (US) | 2024-08-22 | — | — | WO | disclosed |
| CN-221531069-U | Photovoltaic arrester monitor | 南京法欧电气有限公司 | 2024-08-13 | — | — | CN | disclosed |
| CN-111819779-B | Power supply | LG伊诺特有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-112369124-B | Light source driving device and method thereof | LG伊诺特有限公司 | 2023-06-06 | — | — | CN | disclosed |
| US-11661603-B2 | Compositions and methods for inhibiting ALDH2 expression | DICERNA PHARMACEUTICALS, INC. (US) | 2023-05-30 | — | — | US | disclosed |
| US-11572562-B2 | Compositions and methods for inhibiting GYS2 expression | DICERNA PHARMACEUTICALS, INC. (US) | 2023-02-07 | — | — | US | disclosed |
| CN-217741368-U | CC signal circuit of alternating current charging gun | 四川永贵科技有限公司 | 2022-11-04 | — | — | CN | disclosed |
| CN-114825939-A | High-precision switching power supply circuit based on double-group output of single transformer | 冠捷电子科技(福建)有限公司 | 2022-07-29 | — | — | CN | disclosed |
| CN-114448227-B | Photovoltaic inverter system and regulating circuit thereof | 浙江日风电气股份有限公司 | 2022-07-08 | — | — | CN | disclosed |
| US-20220186229-A1 | METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF CYP27A1 | DICERNA PHARMACEUTICALS, INC. | 2022-06-16 | — | — | US | disclosed |
| US-20220170025-A1 | COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION IN THE CENTRAL NERVOUS SYSTEM | NOVO NORDISK A/S (DK) | 2022-06-02 | — | — | US | disclosed |
| CN-114448227-A | Photovoltaic inverter system and regulating circuit thereof | 浙江日风电气股份有限公司 | 2022-05-06 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11572562-B2 | Compositions and methods for inhibiting GYS2 expression | GYS2, GYS1, GLS2 | HTT 2714/4885ADRB2 4675/4885BCHE 4434/4885 |
| US-12534730-B2 | Compositions and methods for inhibiting GYS2 expression | GYS2, GYS1, GLS2 | HTT 3267/4885ADRB2 4223/4885BCHE 4581/4885 |
| US-20220186229-A1 | METHODS AND COMPOSITIONS FOR INHIBITING EXPRESSION OF CYP27A1 | RNASE1, CYP7B1, CYP27A1 | HTT 4592/4885ADRB2 3292/4885BCHE 1815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.